Dr. Edward J. Kim, MD, PhD

Dr. Kim practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Kim's NPI, 1033237987, was assigned on March 27, 2007. Dr. Kim graduated from Renaissance School of Medicine at Stony Brook University in 2005. Dr. Kim holds California license A122547.

Dr. Kim's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Kim's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Kim is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Kim to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kim is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Kim's licenses on file in 2 states: California and Michigan.

Dmand AI lists colorectal cancer and multiple myeloma among the conditions Dr. Kim treats.

CMS data shows 554 Medicare services from Dr. Kim across 5 procedure codes in 2024, for 121 Medicare patients. Medicare paid $36,184 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 65 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 63, with 56% women.

In 2024, Dr. Kim wrote 357 Medicare Part D claims for 56 patients. 61% of them were for generic drugs. CMS names the drug for 245 of them, across 12 drugs with 11 or more claims each, at $886,566 in total drug cost. In 2023, CMS named 400 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 68 papers to Dr. Kim, published from 2003 to 2024. 2020 was the busiest year, with 8. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms and Adenocarcinoma. Dr. Kim has published most often in J Surg Educ. Dr. Kim's most frequent co-authors are May T. Cho, MD, Aaron M. Fischman, MD and Jasmine C. Huynh, MD.

Dmand AI links Dr. Kim to 5 clinical trials, 2 of them phase 1 studies. Conditions studied include Carcinoma, Hepatocellular, Liver Neoplasms and Klatskin Tumor.

CMS Open Payments shows 124 general payments to Dr. Kim from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Eisai Inc. paid the most, $109,261. It also lists 7 research payments totaling $11,982 from 2016 to 2024.

Dmand AI lists 1 award for Dr. Kim, most recently CMS Stage 1 EHR in 2013.

Dr. Kim graduated from Renaissance School of Medicine at Stony Brook University in 2005.

Dr. Kim is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.